CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by dos Santos Silva, I.
Right arrow Articles by Peto, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by dos Santos Silva, I.
Right arrow Articles by Peto, J.
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 449-455, March 2006
© 2006 American Association for Cancer Research

The Insulin-Like Growth Factor System and Mammographic Features in Premenopausal and Postmenopausal Women

Isabel dos Santos Silva1, Nichola Johnson2, Bianca De Stavola1, Gabriela Torres-Mejía1, Olivia Fletcher2, Diane S. Allen3, Naomi E. Allen4, Timothy J. Key4, Ian S. Fentiman3, Jeff M.P. Holly5 and Julian Peto1,6

1 Cancer Research UK Epidemiology and Genetics Group, Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom; 2 The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom; 3 Academic Oncology Unit, Guy's Hospital, London, United Kingdom; 4 Cancer Research UK Epidemiology Unit, University of Oxford, Oxford, United Kingdom; 5 Division of Surgery, Bristol Royal Infirmary, Bristol, United Kingdom; and 6 Cancer Research UK Epidemiology and Genetics Group, The Institute of Cancer Research, Sutton, United Kingdom

Requests for reprints: Isabel dos Santos Silva, Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom. Phone: 44-20-7927-2113; Fax: 44-20-7580-6897; E-mail: isabel.silva{at}lshtm.ac.uk

High levels of circulating insulin-like growth factor-I (IGF-I) and its major binding protein (IGFBP-3) at premenopausal ages have been associated with an increased breast cancer risk. We conducted a cross-sectional study (215 premenopausal women and 241 after natural menopause) nested within the Guernsey prospective studies to examine the relationship between the IGF system and mammographic features of the breast. The mammographically dense area in the breast increased with increasing serum levels of IGF-I (P for linear trend, Pt = 0.05), IGF-II (Pt = 0.08), and IGFBP-3 (Pt = 0.01) only in premenopausal women. IGF-II and IGFBP-3 serum levels were associated with increases in the mammographically lucent area in both premenopausal (Pt = 0.01 and 0.04, respectively) and postmenopausal women (Pt < 0.001 for both), but these associations were no longer statistically significant after adjustment for body mass index and waist circumference. Neither the IGF-I/IGFBP-3 nor the IGF-II/IGFBP-3 molar ratio was associated with any of these mammographic features. The number of A alleles at a polymorphic locus in the promoter region of the IGFBP-3 gene was associated with increasing mean IGFBP-3 levels in both premenopausal (Pt = 0.01) and postmenopausal (Pt <0.001) women but not with mammographically dense area. These results support the hypothesis that the IGF system may affect the amount of mammographically dense tissue in premenopausal women, possibly by promoting cell proliferation and inhibiting apoptosis in the fibroglandular tissue. The findings also show strong relations between IGF-II and IGFBP-3 levels and the amount of mammographically lucent tissue, reflecting the associations between body adiposity and amount of fat tissue in the breast and between body adiposity and circulating levels of these growth factors. (Cancer Epidemiol Biomarkers Prev 2006;15(3):449–55)




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
C. Palles, N. Johnson, B. Coupland, C. Taylor, J. Carvajal, J. Holly, I. S. Fentiman, I. dos Santos Silva, A. Ashworth, J. Peto, et al.
Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy
Hum. Mol. Genet., May 15, 2008; 17(10): 1457 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Diorio, J. Brisson, S. Berube, and M. Pollak
Genetic Polymorphisms Involved in Insulin-like Growth Factor (IGF) Pathway in Relation to Mammographic Breast Density and IGF Levels
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 880 - 888.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
T. Sellers, C. Vachon, V. Pankratz, C. Janney, Z Fredericksen, K. Brandt, Y Huang, F. Couch, L. Kushi, and J. Cerhan
Association of Childhood and Adolescent Anthropometric Factors, Physical Activity, and Diet with Adult Mammographic Breast Density
Am. J. Epidemiol., August 15, 2007; 166(4): 456 - 464.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Verheus, P. H.M. Peeters, R. Kaaks, P. A.H. van Noord, D. E. Grobbee, and C. H. van Gils
Premenopausal Insulin-Like Growth Factor-I Serum Levels and Changes in Breast Density over Menopause
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 451 - 457.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Bremnes, G. Ursin, N. Bjurstam, S. Rinaldi, R. Kaaks, and I. T. Gram
Insulin-like Growth Factor and Mammographic Density in Postmenopausal Norwegian Women
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 57 - 62.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Lukanova, P. Toniolo, A. Zeleniuch-Jacquotte, K. Grankvist, M. Wulff, A. A. Arslan, Y. Afanasyeva, R. Johansson, P. Lenner, G. Hallmans, et al.
Insulin-like Growth Factor I in Pregnancy and Maternal Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2489 - 2493.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. M. Martin, J. M. P. Holly, G. Davey Smith, and D. Gunnell
Associations of Adiposity from Childhood into Adulthood with Insulin Resistance and the Insulin-Like Growth Factor System: 65-Year Follow-Up of the Boyd Orr Cohort
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3287 - 3295.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.